{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:06:49Z","timestamp":1784934409233,"version":"3.55.0"},"reference-count":74,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Cystic fibrosis (CF), the most common autosomal-recessive genetic disease in the Caucasian population, is characterized by frequent respiratory infections and progressive lung disease. Fungal species are commonly found in patients with CF, and among them, Aspergillus fumigatus is the most frequently isolated. While bacteria, particularly Pseudomonas aeruginosa, have a well-established negative effect on CF lung disease, the impact of fungal infections remains unclear. In patients with CF, inhalation of Aspergillus conidia can cause allergic bronchopulmonary aspergillosis (ABPA), a Th2-mediated lung disease that can contribute to disease progression. Clinical features, diagnostic criteria and treatment of ABPA are still a matter of debate. Given the consequences of a late ABPA diagnosis or the risk of ABPA overdiagnosis, it is imperative that the diagnostic criteria guidelines are reviewed and standardized. Along with traditional criteria, radiological features are emerging as tools for further classification as well as novel immunological tests. Corticosteroids, itraconazole and voriconazole continue to be the bedrock of ABPA therapy, but other molecules, such as posaconazole, vitamin D, recombinant INF-\u03b3 and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators, have been showing positive results. However, few studies have been conducted recruiting CF patients, and more research is needed to improve the prevention and the classification of clinical manifestations as well as to personalize treatment. Early recognition and early treatment of fungal infections may be fundamental to prevent progression of CF disease. The aim of this narrative review is to give an update on ABPA in children with CF.<\/jats:p>","DOI":"10.3390\/pathogens9090716","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T08:11:19Z","timestamp":1598861479000},"page":"716","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: An Update on the Newest Diagnostic Tools and Therapeutic Approaches"],"prefix":"10.3390","volume":"9","author":[{"given":"Claudia","family":"Lattanzi","sequence":"first","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Messina","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fainardi","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Candida","family":"Tripodi","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Pisi","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2174\/13816128113199990349","article-title":"Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease","volume":"19","author":"Eickmeier","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_2","first-page":"617","article-title":"Cystic fibrosis: Microbiology and host response","volume":"63","author":"Zemanick","year":"2016","journal-title":"Pediatr. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2007.06.006","article-title":"Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis","volume":"7","author":"Valenza","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref_5","first-page":"S75","article-title":"The myriad challenges of respiratory fungal infection in cystic fibrosis","volume":"53","author":"Tracy","year":"2018","journal-title":"Pediatr Pneumol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"105683","DOI":"10.1016\/j.mimet.2019.105683","article-title":"The prevalence of Aspergillus fumigatus in early cystic fibrosis disease is underestimated by culture-based diagnostic methods","volume":"164","author":"Reece","year":"2019","journal-title":"J. Microbiol. Methods"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/17476348.2014.915751","article-title":"What is the importance of classifying Aspergillus disease in cystic fibrosis patients?","volume":"8","author":"Jones","year":"2014","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/mmy\/myv119","article-title":"Chronic Aspergillus fumigatus colonization of the pediatric cystic fibrosis airway is common and may be associated with a more rapid decline in ling function","volume":"54","author":"Saunders","year":"2016","journal-title":"Sabouraudia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201810-1919OC","article-title":"Changing prevalence of lower airway infections in young children with cystic fibrosis","volume":"200","author":"Breuer","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","unstructured":"Sisodia, J., and Bajaj, T. (2020). Allergic Bronchopulmonary Aspergillosis (ABPA). StatPearls, StatPearls Publishing."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/ppul.24465","article-title":"An investigation into biomarkers for the diagnosis of ABPA and Aspergillus disease in cystic fibrosis","volume":"54","author":"Keown","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/17476348.2016.1249853","article-title":"Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis","volume":"10","author":"Agarwal","year":"2016","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complications chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med. Mycol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jaip.2017.03.033","article-title":"Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis","volume":"5","author":"Gothe","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: Review of literature and proposed of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin. Exp. Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","article-title":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","volume":"17","author":"Hong","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ppul.21240","article-title":"Risk factors for Aspergillus colonization and Allergic Bronchopulmonary Aspergillosis in children with cystic fibrosis","volume":"45","author":"Jubin","year":"2010","journal-title":"Pediatr. Pulmonol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ppul.20333","article-title":"Pulse intravenous metilprednisolone for resistant allergic bronchipulmonary aspergillosis in cystic fibrosis","volume":"41","author":"Thompson","year":"2006","journal-title":"Pediatr. Pulmonol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/pai.2008.0505","article-title":"HLADR, IL-4RA, and IL-10: Genetic risk factors in allergic bronchopulmonary aspergillosis","volume":"21","author":"Knutsen","year":"2008","journal-title":"Pediatr. Asthma Allergy Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/429964","article-title":"Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis","volume":"191","author":"Brouard","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13223-016-0152-y","article-title":"Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: A genetic association study","volume":"12","author":"Overton","year":"2016","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1002\/eji.201344404","article-title":"The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease","volume":"44","author":"Kolwijck","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1128\/IAI.72.9.4996-5003.2004","article-title":"Role of antibiotics and fungal microbiota in driving pulmonary allergic responses","volume":"72","author":"Noverr","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1080\/13693780500052255","article-title":"Pathophysiology and immunology of allergic bronchopulmonary aspergillosis","volume":"43","author":"Moss","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mib.2017.10.007","article-title":"Lung epithelium: Barrier immunity to inhaled fungi and driver of fungal-associated allergic asthma","volume":"40","author":"Wiesner","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1165\/rcmb.2010-0224OC","article-title":"Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses","volume":"44","author":"Mueller","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Boil."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1240342","article-title":"Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4","volume":"341","author":"Millien","year":"2013","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1586\/eri.10.93","article-title":"Cracking the Toll-like receptor code in fungal infections","volume":"8","author":"Cunha","year":"2010","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.4049\/jimmunol.173.12.7406","article-title":"TLRs govern neutrophil activity in aspergillosis","volume":"173","author":"Bellocchio","year":"2004","journal-title":"J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1398-9995.2003.00129.x","article-title":"Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis","volume":"59","author":"Knutsen","year":"2004","journal-title":"Allergy"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dietschmann, A., Schruefer, S., Krappmann, S., and Voehringer, D. (2020). Th2 cells promote eosinophil independent pathology in a murine model of allergic bronchopulmonary aspergillosis. Eur. J. Immunol., [published online ahead of print, 28 February 2020].","DOI":"10.1002\/eji.201948411"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1093\/mmy\/myy076","article-title":"Pathophysiological aspects of Aspergillus colonization in disease","volume":"57","author":"Gago","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11046-017-0190-0","article-title":"Aspergillus Bronchitis in Patients with Cystic Fibrosis","volume":"183","author":"Brandt","year":"2018","journal-title":"Mycopathologia"},{"key":"ref_37","first-page":"e4550","article-title":"Diagnosing allergic bronchopulmonary aspergillosis: A review","volume":"11","author":"Patel","year":"2019","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/archdischild-2016-311132","article-title":"Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: A European Cystic Fibrosis Society Patient Registry analysis","volume":"102","author":"Kaditis","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/pai.12953","article-title":"Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients","volume":"29","author":"Schelstraete","year":"2018","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/thoraxjnl-2018-211550","article-title":"Aspergillus and progression of lung disease in children with cystic fibrosis","volume":"74","author":"Harun","year":"2018","journal-title":"Thorax"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1164\/rccm.201908-1585OC","article-title":"Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis","volume":"201","author":"Breuer","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s10096-015-2474-y","article-title":"Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship","volume":"34","author":"Noni","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Beswick, E., Amich, J., and Gago, S. (2020). Factoring in the Complexity of the Cystic Fibrosis Lung to Understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions. Pathogens, 9.","DOI":"10.3390\/pathogens9080639"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4168\/aair.2016.8.4.282","article-title":"Allergic bronchopulmonary aspergillosis: A perplexing clinical entity","volume":"8","author":"Shah","year":"2016","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.23822\/EurAnnACI.1764-1489.121","article-title":"Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria","volume":"52","author":"Maleki","year":"2020","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-7022-4-14","article-title":"Fungal allergy in asthma-state of the art and research needs","volume":"4","author":"Denning","year":"2014","journal-title":"Clin. Transl. Allergy"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Novel immunologic classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2011.12.970","article-title":"Fungi and allergic lower respiratory tract diseases","volume":"129","author":"Knutsen","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.rmed.2012.03.001","article-title":"Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long term outcomes","volume":"106","author":"Agarwal","year":"2012","journal-title":"Respir. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/crj.13111","article-title":"The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis","volume":"14","author":"Lu","year":"2020","journal-title":"Clin. Respir. J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Peccini, L., Pennoni, S., Mencarini, V., Saponara, M., Palladino, N., Principi, N., Pennoni, G., and Esposito, S. (2019). A peculiar case of pneumonia due to Mycoplasma pneumoniae in a child with cystic fibrosis and sensibilization to Aspergillus fumigatus. Pathogens, 9.","DOI":"10.3390\/pathogens9010015"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.3389\/fimmu.2019.03149","article-title":"Evaluation of Cellular Responses for the Diagnosis of Allergic Bronchopulmonary Mycosis: A Preliminary Study in Cystic Fibrosis Patients","volume":"10","author":"Michel","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11882-019-0889-8","article-title":"Correction to: Basophil Activation Test: Old and New Applications in Allergy","volume":"19","author":"Hemmings","year":"2019","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_54","first-page":"e4538","article-title":"Treating allergic bronchopulmonary aspergillosis: A review","volume":"11","author":"Patel","year":"2019","journal-title":"Cureus"},{"key":"ref_55","first-page":"35","article-title":"Question 11: How should allergic bronchopulmonary aspergillosis (ABPA) be managed in cystic fibrosis?","volume":"24","author":"Ohn","year":"2017","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/1817-1737.140130","article-title":"Allergic bronchopulmonary aspergillosis: A clinical review of 24 patients: Are we right in frequent serologic monitoring?","volume":"9","author":"Natarajan","year":"2014","journal-title":"Ann. Thorac. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.chest.2018.01.005","article-title":"A randomized trial of Itraconazole vs Prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"153","author":"Agarwal","year":"2018","journal-title":"Chest"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/ers.12.35","article-title":"What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization","volume":"6","author":"Agarwal","year":"2012","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Elphick, H.E., and Southern, K.W. (2016). Antifungal therapies for allergic bronchopulmonaryaspergillosis in people with cystic fibrosis. Cochrane Database Syst. Rev., 11.","DOI":"10.1002\/14651858.CD002204.pub4"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.200805-737OC","article-title":"Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study","volume":"179","author":"Denning","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jaad.2014.10.023","article-title":"Voriconazole phototoxicity in children: A retrospective review","volume":"72","author":"Sheu","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.amjmed.2020.02.025","article-title":"Pulmonary Aspergillosis: What the Generalist Needs to Know","volume":"133","author":"Gao","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11908-011-0220-x","article-title":"Long-term voriconazole and skin cancer: Is there cause for concern?","volume":"13","author":"Clancy","year":"2011","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Rivero-Menendez, O., Alastruey-Izquierdo, A., Mellado, E., and Cuenca-Estrella, M. (2016). Triazole resistance in Aspergillus spp.: A worldwide problem?. J. Fungi, 2.","DOI":"10.3390\/jof2030021"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/jac\/dkz075","article-title":"Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"74","author":"Periselneris","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/mmy\/myz015","article-title":"Posaconazole therapy in children with cystic fibrosis and Aspergillus-related lung disease","volume":"58","author":"Patel","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jacobs, S.E., Saez-Lacy, D., Wynkoop, W., and Walsh, T.J. (2017). Successful Treatment of Allergic Bronchopulmonary Aspergillosis with Isavuconazole: Case Report and Review of the Literature. Open Forum Infectious Diseases, Oxford University Press.","DOI":"10.1093\/ofid\/ofx040"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of Omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2019.07.011","article-title":"Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis","volume":"19","author":"Koutsokera","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.rmed.2017.11.007","article-title":"Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis","volume":"133","author":"Perisson","year":"2017","journal-title":"Respir. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13223-019-0397-3","article-title":"Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: Case series","volume":"16","author":"Zhang","year":"2020","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1172\/JCI42388","article-title":"Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis","volume":"120","author":"Kreindler","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40733-015-0003-5","article-title":"Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: A phase one open-label study","volume":"1","author":"Nguyen","year":"2015","journal-title":"Asthma Res. Pr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1513\/AnnalsATS.201902-122OC","article-title":"Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data","volume":"16","author":"Frost","year":"2019","journal-title":"Ann. Am. Thorac. Soc."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/9\/9\/716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:04:55Z","timestamp":1760177095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/9\/9\/716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":74,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["pathogens9090716"],"URL":"https:\/\/doi.org\/10.3390\/pathogens9090716","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]}}}